PCI Biotech Holding ASA (PCIB) — Tangible Net Worth Ratio
PCI Biotech Holding ASA (PCIB) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (Nkr0.00) from net assets (Nkr12.52 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See PCIB net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PCI Biotech Holding ASA Tangible Net Worth Ratio (2008–2024)
This chart shows how PCI Biotech Holding ASA's Tangible Net Worth Ratio has changed across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of Nkr12.52 Million with intangible assets of Nkr0.00 NOK. See PCI Biotech Holding ASA (PCIB) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for PCI Biotech Holding ASA (2008–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for PCI Biotech Holding ASA from 2008 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see PCI Biotech Holding ASA market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (NOK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | Nkr23.45 Million | Nkr0.00 | Nkr31.21 Million | ▲ +0.0 pp |
| 2023 | 100.0% | Nkr39.04 Million | Nkr0.00 | Nkr44.05 Million | ▲ +0.0 pp |
| 2022 | 100.0% | Nkr57.40 Million | Nkr0.00 | Nkr63.48 Million | ▲ +0.0 pp |
| 2021 | 100.0% | Nkr113.79 Million | Nkr0.00 | Nkr135.98 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Nkr189.24 Million | Nkr0.00 | Nkr209.12 Million | ▲ +0.0 pp |
| 2019 | 100.0% | Nkr254.83 Million | Nkr0.00 | Nkr282.03 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Nkr339.95 Million | Nkr0.00 | Nkr357.06 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Nkr41.84 Million | Nkr0.00 | Nkr58.44 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Nkr13.09 Million | Nkr0.00 | Nkr22.40 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Nkr44.28 Million | Nkr0.00 | Nkr56.40 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Nkr9.11 Million | Nkr0.00 | Nkr20.38 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Nkr43.40 Million | Nkr0.00 | Nkr52.74 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Nkr69.71 Million | Nkr0.00 | Nkr78.20 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Nkr92.53 Million | Nkr0.00 | Nkr100.17 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Nkr105.42 Million | Nkr0.00 | Nkr114.54 Million | ▲ +0.1 pp |
| 2009 | 99.9% | Nkr35.08 Million | Nkr27.00K | Nkr41.53 Million | ▲ +0.1 pp |
| 2008 | 99.8% | Nkr49.30 Million | Nkr76.00K | Nkr54.58 Million | — |